Pricing Log in Create free account

Alaunos Therapeutics, Inc. (TCRT) vs Traws Pharma, Inc. (TRAW)

Alaunos Therapeutics, Inc. and Traws Pharma, Inc. are both Biotechnology companies. Alaunos Therapeutics, Inc. and Traws Pharma, Inc. are of similar size ($6.4M and $6.2M). Traws Pharma, Inc. grew revenue faster over the last twelve months: 1,159.3% against −17.7%. Across the 13 metrics below, Traws Pharma, Inc. leads on 10 and Alaunos Therapeutics, Inc. on 3.

Valuation

Metric TCRT TRAW Biotechnology median
P/E n/m n/m 8.50
P/S 456.87 2.06 9.71
P/B 9.81 3.47 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1,552.30 0.30 9.21
Earnings yield (72.62%) (475.68%) (33.15%)
Free cash flow yield (20.65%) (287.29%) (25.50%)

Profitability

Metric TCRT TRAW Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (185.95%) (319.42%) (56.36%)
Return on assets (128.30%) (117.35%) (48.04%)
Return on invested capital (480.35%) 0.00% 0.00%

Growth

Metric TCRT TRAW Biotechnology median
Revenue growth (TTM) (17.65%) 1,159.29% 6.02%
EPS growth (last fiscal year) 24.66% 100.76% 30.26%
Revenue growth, 5-year CAGR (49.08%) 64.59% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TCRT TRAW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.77 0.93 4.72
Net debt to EBITDA 0.33 0.21 0.96

Dividend

Metric TCRT TRAW Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric TCRT TRAW Biotechnology median
Market cap 6.38m 6.20m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack